Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Applied Therapeutics (APLT) Change in Acquisitions & Divestments (2023)

Historic Change in Acquisitions & Divestments for Applied Therapeutics (APLT) over the last 1 years, with Q1 2023 value amounting to $8.9 million.

  • Applied Therapeutics' Change in Acquisitions & Divestments changed N/A to $8.9 million in Q1 2023 from the same period last year, while for Dec 2023 it was $8.9 million, marking a year-over-year change of. This contributed to the annual value of $8.9 million for FY2023, which is 8846.33% down from last year.
  • Applied Therapeutics' Change in Acquisitions & Divestments amounted to $8.9 million in Q1 2023.
  • In the past 5 years, Applied Therapeutics' Change in Acquisitions & Divestments registered a high of $8.9 million during Q1 2023, and its lowest value of $8.9 million during Q1 2023.